Entourage Updates Timing of Fiscal Year 2021 Financial Results Call to May 3, 2022
April 22, 2022 08:02 ET
|
Entourage Health Corp.
Company reaffirms preliminary fiscal year 2021 record revenue of $54.8 million(1)Results to be filed after-market May 2, 2022, with management hosting a call on following day TORONTO, April 22, 2022...
Entourage Health Debuts New 2022 Color Cannabis Branding Campaign and Celebrates All-Female-Led Marketing and Promotions Team
March 08, 2022 09:37 ET
|
Entourage Health Corp.
TORONTO, March 08, 2022 (GLOBE NEWSWIRE) -- Entourage Health Corp. (formerly WeedMD Inc.) (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of...
Entourage Health and LiUNA Pension Fund Upsize Credit Facility with Additional $20 Million in Non-Dilutive Financing
December 24, 2021 12:18 ET
|
Entourage Health Corp.
TORONTO, Dec. 24, 2021 (GLOBE NEWSWIRE) -- Entourage Health Corp. (formerly WeedMD Inc.) (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of...
Entourage Health Launches Cannabis-Infused Soft Chews for Starseed Medicinal Line
November 29, 2021 08:30 ET
|
Entourage Health Corp.
TORONTO, Nov. 29, 2021 (GLOBE NEWSWIRE) -- Entourage Health Corp. (formerly WeedMD Inc.) (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of...
Entourage Health Launches Mary’s Medicinals Transdermal Cannabis Patches in Canada
September 16, 2021 08:57 ET
|
Entourage Health Corp.
Innovative suite of Mary’s line-up produced locally now includes Transdermal Patches in CBD, THC and 1:1 formulations that offer a novel, alternative path to cannabinoid deliveryWith over 40 medical...
WeedMD to Host Fiscal Year End 2020 Conference Call on May 31st
May 21, 2021 08:18 ET
|
WeedMD Rx Inc.
Company financials to be filed after market on May 28, 2021 and operational outlook to be provided during call, including first quarter 2021 record milestones achieved TORONTO, May 21, 2021 (GLOBE...
WeedMD to Host Fiscal Year-End 2020 Conference Call on April 30, 2021
April 09, 2021 09:02 ET
|
WeedMD Rx Inc.
TORONTO, April 09, 2021 (GLOBE NEWSWIRE) -- WeedMD Inc. (TSX-V:WMD) (OTCQX:WDDMF) (FSE:4WE) (“WeedMD” or the “Company”), a federally licensed producer and distributor of medical-grade cannabis,...
WeedMD’s Color Cannabis Expands Product Portfolio with Debut of Live Resin in Pedro’s Sweet Sativa Cultivar
March 25, 2021 08:00 ET
|
WeedMD Rx Inc.
TORONTO, March 25, 2021 (GLOBE NEWSWIRE) -- WeedMD Inc. (TSX-V:WMD) (OTCQX:WDDMF) (FSE:4WE) (“WeedMD” or the “Company”), a federally licensed producer and distributor of medical-grade cannabis, is...
WeedMD Announces Mary’s Medicinals Topicals Product Release in Canada
February 16, 2021 08:26 ET
|
WeedMD Rx Inc.
Acclaimed Mary’s Medicinals Transdermal Compound, produced exclusively in Canada by WeedMD, with expected availability to Starseed Medicinal’s patients starting late February, 2021Mary’s Medicinals...
WeedMD Announces the Development of New Cannabis 2.0 Products Featuring Hash, Live Resin and Rosin Extracts for Adult-Use Lineup
January 19, 2021 08:06 ET
|
WeedMD Rx Inc.
TORONTO, Jan. 19, 2021 (GLOBE NEWSWIRE) -- WeedMD Inc. (TSX-V:WMD) (OTCQX:WDDMF) (FSE:4WE) (“WeedMD” or the “Company”), a federally licensed producer and distributor of medical-grade cannabis, is...